--- title: "CANbridge Pharmaceuticals (1228) stock and investor profile" url: "https://aibio.space/companies/canbridge-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "CANbridge Pharmaceuticals Inc. (HKEX: 1228), China. The directory classifies it as Pharmaceuticals: Major." --- 1228 CANbridge Pharmaceuticals Inc. HKEX · China # CANbridge Pharmaceuticals (1228) news CANbridge Pharmaceuticals Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1228, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest CANbridge Pharmaceuticals news We have not published a story on CANbridge Pharmaceuticals yet. When there is news, it will appear here. ## CANbridge Pharmaceuticals at a glance - **Ticker**: 1228 - **Listing**: HKEX - **Country**: China ### Related companies - [Shanghai Junshi Biosciences Co.](https://aibio.space/companies/shanghai-junshi-biosciences/) SSE: 688180 - [VISEN Pharmaceuticals](https://aibio.space/companies/visen-pharmaceuticals/) HKEX: 2561 - [InnoCare Pharma](https://aibio.space/companies/innocare-pharma/) SSE: 688428 - [Gansu Longshenrongfa Pharmaceutical Industry Co.](https://aibio.space/companies/gansu-longshenrongfa-pharmaceutical-industry/) SZSE: 300534 - [China Medical System Holdings](https://aibio.space/companies/china-medical-system/) HKEX: 867 - [Henan Lingrui Pharmaceutial Co.](https://aibio.space/companies/henan-lingrui-pharmaceutial/) SSE: 600285 - [Shandong Boan Biotechnology Company., Limited.](https://aibio.space/companies/shandong-boan-biotechnology/) HKEX: 6955 - [New Ray Medicine International Holding](https://aibio.space/companies/new-ray-medicine-international/) HKEX: 6108 ### Also on HKEX - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) 9966 - [Zhaoke Ophthalmology](https://aibio.space/companies/zhaoke-ophthalmology/) 6622 - [AIM Vaccine Co.](https://aibio.space/companies/aim-vaccine/) 6660 - [China Traditional Chinese Medicine Holdings Co.](https://aibio.space/companies/china-traditional-chinese-medicine/) 570 - [B&K Corporation](https://aibio.space/companies/b-k/) 2396 - [3D Medicines](https://aibio.space/companies/3d-medicines/) 1244 ## Questions about CANbridge Pharmaceuticals What is the ticker symbol of CANbridge Pharmaceuticals? CANbridge Pharmaceuticals Inc. trades under the ticker 1228 on HKEX. Where is CANbridge Pharmaceuticals listed? CANbridge Pharmaceuticals Inc. is listed on HKEX. Which country or territory is CANbridge Pharmaceuticals listed under? Our directory records CANbridge Pharmaceuticals Inc. under China. What does CANbridge Pharmaceuticals do? Our directory classifies CANbridge Pharmaceuticals Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of CANbridge Pharmaceuticals? The ISIN recorded for CANbridge Pharmaceuticals Inc. is KYG1821D1097. Does aibio.space cover CANbridge Pharmaceuticals? aibio.space lists CANbridge Pharmaceuticals Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to CANbridge Pharmaceuticals? Companies in our directory listed in the same country and business area as CANbridge Pharmaceuticals: Shanghai Junshi Biosciences Co., VISEN Pharmaceuticals, InnoCare Pharma, Gansu Longshenrongfa Pharmaceutical Industry Co., China Medical System Holdings, Henan Lingrui Pharmaceutial Co.. ## Investor discussion: CANbridge Pharmaceuticals Members talk about CANbridge Pharmaceuticals (1228). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at CANbridge Pharmaceuticals, newest first. Each line links the filing it comes from. 1. 2026-06-02 Financings Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS; AND (5) NOTICE OF AGM. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060201728.pdf) 2. 2026-03-10 Financings Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0311/2026031100001.pdf) 3. 2026-02-15 Financings Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0216/2026021600003.pdf) 4. 2025-11-19 Financings Share or debt issue: PROPOSED REFRESHMENT OF GENERAL MANDATE AND NOTICE OF EGM. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1119/2025111900335.pdf) 5. 2025-09-28 Financings Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0928/2025092800009.pdf) 6. 2025-09-15 Financings Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0915/2025091501588.pdf) 7. 2025-08-27 Financings Share or debt issue: (1) COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE; (2) CONTINUING CONNECTED TRANSACTION PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES; AND (3) APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND NOMINATION AND CORPORATE GOVERNANCE COMMITTEE MEMBER. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082701211.pdf) 8. 2025-08-13 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0813/2025081300061.htm) 9. 2025-08-12 Listings Trading status: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201538.pdf) 10. 2025-08-12 Listings Trading status: TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081200066.pdf) 11. 2025-08-12 Listings Trading status: EXCHANGE NOTICE - TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081200045.htm) 12. 2025-06-06 Financings Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF AGM. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601205.pdf) 13. 2025-02-25 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE EARLY TERMINATION OF A LEASE AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0225/2025022500170.pdf) ## Press releases Headlines of CANbridge Pharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026082801091.pdf) 2. 2026-08-17 HKEXnews [VOLUNTARY ANNOUNCEMENT - NHIA REIMBURSEMENT APPROVAL OF LIVMARLI IN TAIWAN](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0818/2026081800013.pdf) 3. 2026-08-05 HKEXnews [(1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0806/2026080600007.pdf) 4. 2026-08-03 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 3, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0803/2026080303223.pdf) 5. 2026-07-30 HKEXnews [VOLUNTARY ANNOUNCEMENT - EXPANSION OF GAURUNNING (VELAGLUCERASE-BETA FOR INJECTION) INTO NORTH AFRICAN MARKET](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0730/2026073000908.pdf) 6. 2026-07-15 HKEXnews [WuXi Biologics Service Procurement Framework Agreement](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 7. 2026-07-15 HKEXnews [NOTICE OF THE EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0715/2026071501484.pdf) 8. 2026-07-15 HKEXnews [CONTINUING CONNECTED TRANSACTIONS - WUXI BIOLOGICS SERVICE PROCUREMENT FRAMEWORK AGREEMENT AND NOTICE OF THE EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0715/2026071501468.pdf) 9. 2026-07-09 HKEXnews [DELAY IN DESPATCH OF CIRCULAR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0709/2026070900308.pdf) 10. 2026-06-23 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 23, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062300488.pdf) 11. 2026-06-16 HKEXnews [CONTINUING CONNECTED TRANSACTIONS: WUXI BIOLOGICS SERVICE PROCUREMENT FRAMEWORK AGREEMENT AND BAHEAL MEDICAL SERVICE PROCUREMENT FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0616/2026061601456.pdf) 12. 2026-06-02 HKEXnews [NOTICE OF AGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060201762.pdf) 13. 2026-06-02 HKEXnews [(1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS; AND (5) NOTICE OF AGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060201728.pdf) 14. 2026-04-12 HKEXnews [GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041300009.pdf) 15. 2026-03-30 HKEXnews [RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE AND PROCESS AGENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0331/2026033100017.pdf) 16. 2026-03-30 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033004382.pdf) 17. 2026-03-10 HKEXnews [CONTINUING CONNECTED TRANSACTIONS PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0311/2026031100003.pdf) 18. 2026-03-10 HKEXnews [COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0311/2026031100001.pdf) 19. 2026-02-20 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT REGARDING THE GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0220/2026022000350.pdf) 20. 2026-02-15 HKEXnews [SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0216/2026021600003.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1228 on TradingView](https://www.tradingview.com/symbols/HKEX-1228/). ## Listing details CANbridge Pharmaceuticals Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1228, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: CANbridge Pharmaceuticals Inc. - **Ticker**: 1228 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG1821D1097 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1228/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/canbridge-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "CANbridge Pharmaceuticals (1228) stock and investor profile", 2026-10-31, https://aibio.space/companies/canbridge-pharmaceuticals/